WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 3, 2004, 24(9):2212-2225; doi:10.1523/JNEUROSCI.4847-03.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakajima, A.
Right arrow Articles by Nabeshima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakajima, A.
Right arrow Articles by Nabeshima, T.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Role of Tumor Necrosis Factor-{alpha} in Methamphetamine-Induced Drug Dependence and Neurotoxicity

Akira Nakajima,1 * Kiyofumi Yamada,1,2 * Taku Nagai,1 Takehisa Uchiyama,1 Yoshiaki Miyamoto,1 Takayoshi Mamiya,1 Jue He,1 Atsumi Nitta,1 Makoto Mizuno,1 Manh Hung Tran,1 Aika Seto,1 Masako Yoshimura,1 Kiyoyuki Kitaichi,3 Takaaki Hasegawa,3 Kuniaki Saito,4 Yasuhiro Yamada,4 Mitsuru Seishima,4 Kenji Sekikawa,5 Hyoung-Chun Kim,6 and Toshitaka Nabeshima1

1Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan, 2Laboratory of Neuropsychopharmacology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa 920-0934, Japan, 3Department of Medical Technology, Nagoya University School of Health Sciences, Nagoya 461-8673, Japan, 4Department of Laboratory Medicine, Gifu University School of Medicine, Gifu 500-8705, Japan, 5Department of Immunology, National Institute of Animal Health, Tsukuba 305-0856, Japan, and 6Neurotoxicology Program, College of Pharmacy, Kangwon National University, Chunchon 200-701, South Korea

Tumor necrosis factor-{alpha} (TNF-{alpha}), a proinflammatory cytokine, is now emerging as an important modulator of the function of the CNS. Methamphetamine (METH) is a widely abused psychostimulant that causes euphoria, hyperactivity, and drug dependence. High doses of METH cause long-term neurotoxicity in dopaminergic neurons. In this study, we investigated a role of TNF-{alpha} in METH-induced dependence and neurotoxicity. Repeated treatment with METH (2 mg/kg for 5 d) in rats induced a significant increase in TNF-{alpha} mRNA and protein expression in the brain. Exogenous TNF-{alpha} (1-4 µg) blocked locomotor-stimulating and rewarding effects of METH, as well as METH (4 mg/kg; four times at 2 hr intervals)-induced dopaminergic neurotoxicity in mice. To examine a role of endogenous TNF-{alpha} in behavioral and neurochemical effects of METH, we used mice with targeted deletions of the TNF-{alpha} gene. TNF-{alpha}-(-/-) mice showed enhanced responses to the locomotor-sensitizing, rewarding, and neurotoxic effects of METH compared with wild-type mice. We also examined the role of TNF-{alpha} in METH-induced dopamine (DA) release and uptake in vitro and in vivo in C57BL/6 mice. Exogenous TNF-{alpha} (4 µg) attenuated the METH-induced increase in extracellular striatal DA in vivo and potentiated striatal DA uptake into synaptosomes in vitro and in vivo. Furthermore, TNF-{alpha} activated vesicular DA uptake by itself and diminished the METH-induced decrease in vesicular DA uptake. Our findings suggest that TNF-{alpha} plays a neuroprotective role in METH-induced drug dependence and neurotoxicity by activating plasmalemmal and vesicular DA transporter as well as inhibiting METH-induced increase in extracellular DA levels.

Key words: addiction; reward; accumbens; gene expression; TNF; neuroprotection


Received Aug 1, 2003; revised January 17, 2004; accepted January 18, 2004.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Niwa, A. Nitta, H. Mizoguchi, Y. Ito, Y. Noda, T. Nagai, and T. Nabeshima
A Novel Molecule "Shati" Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference
J. Neurosci., July 11, 2007; 27(28): 7604 - 7615.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Zhan, F. Serrano, P. Fenik, R. Hsu, L. Kong, D. Pratico, E. Klann, and S. C. Veasey
NADPH Oxidase Mediates Hypersomnolence and Brain Oxidative Injury in a Murine Model of Sleep Apnea
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 921 - 929.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-